Counts of cells with nuclear FOXP1 expression in immunochemistry showed a significant difference between the two transduced cell lines (p < 0.05)(Figure 4B), and also between the two groups of PMBL and DLBCL patients (p < 0.05)(Figure 4C). The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.